Relationship of dimethylglycine, choline, and betaine with oxoproline in plasma of pregnant women and their newborn infants

Journal of Nutrition

Volumn 137, Issue 12, 2007, Pages 2641-2646

  Friesen, Russell W ^a   Novak, Elizabeth M ^a   Hasman, David ^a   Innis, Sheila M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETAINE; CHOLINE; CHOLINE DEHYDROGENASE; DIMETHYLGLYCINE; GLUTATHIONE; GLYCINE; PYROGLUTAMIC ACID;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; GESTATION PERIOD; GLUTATHIONE METABOLISM; HUMAN; MATERNAL PLASMA; NEWBORN; PREGNANT WOMAN;

EID: 37149030672     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/137.12.2641     Document Type: Article

References (49)

1. Zeisel SH. Choline: critical role during fetal development and dietary requirements in adults. Annu Rev Nutr. 2006;26:229-50.
2. Phillis JW. Acetylcholine release from the central nervous system: a 50-year retrospective. Crit Rev Neurobiol. 2005;17:161-217.
3. Zeisel SH, Blusztajn JK. Choline and human nutrition. Annu Rev Nutr. 1994;14:269-96.
4. Depeint F, Bruce WR, Shangrai N, Mehta R, O'Brien PJ. Mitochondrial function and toxicity: role of B vitamins on the one-carbon transfer pathways. Chem Biol Interact. 2006;163:113-32.
5. Ueland PM, Holm PI, Hustad S. Betaine: a key modulator of one-carbon metabolism and homocysteine status. Clin Chem Lab Med. 2005;43:1069-75.
6. Stead LM, Brosnan JT, Brosnan ME, Vance DE, Jacobs RL. Is it time to re-evaluate methyl balance in humans? Am J Clin Nutr. 2006;83:5-10.
7. Grassl SM. Choline transport in human placental brush-border membrane vesicles. Biochim Biophys Acta. 1994;1194:203-13.
8. van der Aa EM, Wouterse AC, Peereboom-Stegeman JH, Russel FG. Uptake of choline into syncytial microvillus membrane vesicles of human term placenta. Biochem Pharmacol. 1994;47:453-6.
9. Molloy AM, Mills JL, Cox C, Daly SF, Conley M, Brody LC, Kirke PN, Scott JM, Ueland PM. Choline and homocysteine interrelations in umbilical cord and maternal plasma at delivery. Am J Clin Nutr. 2005;82:836-42.
10. Ilcol YO, Ozbek R, Hamurtekin E, Ulus IH. Choline status in newborns, infants, children, breast-feeding women, breast-fed infants and human breast milk. J Nutr Biochem. 2005;16:489-99.
11. Shaw GM, Carmichael SL, Yang W, Selvin S, Schaffer DM. Periconceptional dietary intake of choline and betaine and neural tube defects in offspring. Am J Epidemiol. 2004;160:102-9.
12. Cho E, Zeisel SH, Jacques P, Selhub J, Dougherty L, Colditz GA, Willet WC. Dietary choline and betaine assessed by food frequency questionnaire in relation to plasma total homocysteine in the Framingham Offspring Study. Am J Clin Nutr. 2006;83:905-11.
13. Jackson AA. The glycine story. Eur J Clin Nutr. 1991;45:59-65.
14. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr. 2004;134:489-92.
15. Jackson AA, Persaud C, Hall M, Smith S, Evans N, Rutter N. Urinary excretion of 5-L-oxoproline (pyroglutamic acid) during early life in term and preterm infants. Arch Dis Child Fetal Neonatal Ed. 1997;76:F152-7.
16. Paolini CL, Marconi AM, Ronzoni S, Di Noio M, Fennessey PV, Pardi G, Battaglia FC. Placental transport of leucine, phenylalanine, glycine, and proline in intrauterine growth-restricted pregnancies. J Clin Endocrinol Metab. 2001;86:5427-32.
17. Geddie G, Moores R, Meschia G, Fennessey P, Wilkening R, Battaglia FC. Comparison of leucine, serine and glycine transport across the ovine placenta. Placenta. 1996;17:619-27.
18. Cetin I, Marconi AM, Baggiani AM, Buscaglia M, Pardi G, Fennessey PV, Battaglia FC. In vivo placental transport of glycine and leucine in human pregnancies. Pediatr Res. 1995;37:571-5.
19. Jackson AA, Badaloo AV, Forrester T, Hibbert JM, Persaud C. Urinary excretion of 5-oxoproline (pyroglutamic aciduria) as an index of glycine insufficiency in normal man. Br J Nutr. 1987;58:207-14.
20. de Koning TJ, Snell K, Duran M, Berger R, Poll-The BT, Surtees R. L-serine in disease and development. Biochem J. 2003;371:653-61.
21. Brosnan JT, Brosnan ME. The sulfur-containing amino acids: an overview. J Nutr. 2006;136:S1636-40.
22. Lewis RM, Godfrey KM, Jackson AA, Cameron IT, Hanson MA. Low serine hydroxymethyltransferase activity in the human placenta has important implications for fetal glycine supply. J Clin Endocrinol Metab. 2005;90:1594-8.
23. Lu SC. Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J. 1999;13:1169-83.
24. Palekar AG, Tate SS, Meister A. Formation of 5-oxoproline from glutathione in erythrocytes by the gamma-glutamyltranspeptidasecyclotransferase pathway. Proc Natl Acad Sci USA. 1974;71:293-7.
25. Meister A, Griffith OW, Novogrodsky A, Tate SS. New aspects of glutathione metabolism and translocation in mammals. Ciba Found Symp. 1979;72:135-61.
26. Board PG, Moore KA, Smith JE. Purification and properties of gammaglutamylcyclotransferase from human erythrocytes. Biochem J. 1978;173:427-31.
27. Smith JE, Moore K, Board PG. Regulation of gamma-glutamylcysteine utilization in erythrocytes. Enzyme. 1980;25:236-40.
28. Elias SL, Innis SM. Infant plasma trans, n-6, and n-3 fatty acids and conjugated linoleic acids are related to maternal plasma fatty acids, length of gestation, and birth weight and length. Am J Clin Nutr. 2001;73:807-14.
29. Innis SM, Hasman D. Evidence of choline depletion and reduced betaine and dimethylglycine with increased homocysteine in plasma of children with cystic fibrosis. J Nutr. 2006;136:2226-31.
30. Velzing-Aarts FV, Holm PI, Fokkema MR, van der Dijs FP, Ueland PM, Muskiet FA. Plasma choline and betaine and their relation to plasma homocysteine in normal pregnancy. Am J Clin Nutr. 2005;81:1383-9.
31. Richman PG, Meister A. Regulation of gamma-glutamyl-cysteine synthetase by nonallosteric feedback inhibition by glutathione. J Biol Chem. 1975;250:1422-6.
32. Larsson A, Mattsson B. On the mechanism of 5-oxoproline overproduction in 5-oxoprolinuria. Clin Chim Acta. 1976;67:245-53.
33. Eaton BM, Sooranna SR. Regulation of the choline transport system insuperfusedmicrocarrier cultures of BeWo cells. Placenta. 1998;19:663-9.
34. Jackson AA, Persaud C, Werkmeister G, McClelland IS, Badaloo A, Forrester T. Comparison of urinary 5-L-oxoproline (L-pyroglutamate) during normal pregnancy in women in England and Jamaica. Br J Nutr. 1997;77:183-96.
35. Persaud C, McDermott J, De Benoist B, Jackson AA. The excretion of 5-oxoproline in urine, as an index of glycine status, during normal pregnancy. Br J Obstet Gynaecol. 1989;96:440-4.
36. O'Donovan DJ, Fernandes CJ. Free radicals and diseases in premature infants. Antioxid Redox Signal. 2004;6:169-76.
37. Saugstad OD. Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin Neonatol. 2003;8:39-49.
38. Dani C, Cecchi A, Bertini G. Role of oxidative stress as a physiopathologic factor in the preterm infant. Minerva Pediatr. 2004;56:381-94.
39. Njalsson R, Norgren S. Physiological and pathological aspects of GSH metabolism. Acta Paediatr. 2005;94:132-7.
40. Jain A, Mehta T, Auld PA, Rodrigues J, Ward RF, Schwartz MK, Marensson J. Glutathione metabolism in newborns: evidence for glutathione deficiency in plasma bronchoaveolar lavage fluid, and lymphocytes in prematures. Pediatr Pulmonol. 1995;20:160-6.
41. Oliveira CP, da Costa Gayotto LC, Tatai C, Della Bina BI, Janiszewski M, Lima ES, Abdalla DS, Lopasso FP, Laurindo FR, et al. Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet. J Cell Mol Med. 2002;6:399-406.
42. Innis SM, Davidson AG, Melnyk S, James SJ. Choline-related supplements improve abnormal plasma methionine-homocysteine metabolites and glutathione status in children with cystic fibrosis. Am J Clin Nutr. 2007;85:702-8.
43. Bostom AG, Jacques PF, Liaugaudas G, Rogers G, Rosenberg IH, Selhub J. Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour. Arterioscler Thromb Vasc Biol. 2002;22:488-91.
44. Ganji V, Kafai MR. Population references for plasma total homocysteine concentrations for U.S. children and adolescents in the post-folic acid fortification era. J Nutr. 2005;135:2253-6.
45. Brouwer DA, Welten HT, Reijngoud DJ, van Doormaal JJ, Muskiet FA. Plasma folic acid cutoff value, derived from its relationship with homocyst(e)ine. Clin Chem. 1998;44:1545-50.
46. Dalery K, Lussier-Cacan S, Selhub J, Davignon J, Latour Y, Genest J Jr. Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate. Am J Cardiol. 1995;75:1107-11.
47. Malinow MR, Duell PB, Hess DL, Anderson PH, Kruger WD, Phillipson BE, Gluckman RA, Block PC, Upson BM. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med. 1998;338:1009-15.
48. Meydani SN, Meydani M, Blumberg JB, Leka LS, Pedrosa M, Diamond R, Schaefer EJ. Assessment of the safety of supplementation with different amounts of vitamin E in healthy older adults. Am J Clin Nutr. 1998;68:311-8.
49. Boyles AL, Billups AV, Deak KL, Siegel DG, Mehltretter L, Slifer SH, Bassuk AG, Kessler JA, Reed MC, et al. Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Environ Health Perspect. 2006;114:1547-52.